MELANOMA CRITICAL DEBATES - PART 1 ppt
MELANOMA CRITICAL DEBATES - PART 1 ppt
... Magnus [11 ] Norway 78 2.4 (1. 0–5.8) Mackie & Aitchison [12 ] Scotland 11 3 0.6 (0.2 1. 2) Lew et al. [13 ] USA 11 1 2.5 (1. 1–5.8) Rigel et al. [14 ] USA 11 4 2.4 (1. 2–5.0) Elwood et al. [15 ] Canada ... Aitchison [12 ] 11 3 adults 4.7 (2.5–8.8) 2.8 (1. 1–7.4) Lew et al. [13 ] 11 1 teens 2 .1 (1. 1–7.4) Not given Elwood et al. [49] 595 children 1. 9 (not given) 1. 3 (0.9 1. 8)...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 3 pptx
... (rela- tive risk 2–3) [11 ,12 ], blue eyes (relative risk 1. 6) [11 ,12 ], red hair (relative risk 2.4–4) [11 ,12 ] and personal history of blistering sunburn (relative risk 2–3) [11 ,12 ]. Many of these ... red hair. Hum Mol Genet 19 97; 6: 18 91 7. 44 Smith R, Healy E, Siddiqui S et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 19 98; 11 1: 11 9–22....
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 5 ppt
... malignant melanoma: review of 10 86 patients. Br J Surg 19 91; 78: 11 08 10 . 12 MacKie R, Hunter JAA, Aitchison TC, et al. Cutaneous malignant melanoma, Scotland, 19 79–89. Lancet 19 92; 339: 9 71 5. 13 ... of malignant melanoma. Br Med J 19 92; 304: 10 12 15 . 13 MacKie RM. Strategies to reduce mortality from cutaneous malignant melanoma. Arch Dermatol Res 19 94; 287: 13 1...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 7 ppt
... and acquired nevomelanocytic nevi. Arch Dermatol 19 85; 12 1: 12 66–73. 17 Everett M. Histopathology of congenital pigmented nevi. Am J Dermatopathol 19 89; 11 : 11 12 . 18 Hendrickson M, Ross J. Neoplasms arising ... I–III 1 BCG No 2 DTIC 3 DTIC + BCG Fisher et al. [3] 18 1 High-risk I–II 1 None No 2 BCG 3 BCG plus melanoma cells 4 Methyl-CCNU Hill et al. [4] 17 4 I–III 1 N...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 10 pptx
... adhesion molecule -1 (ICAM -1 ) 222 a-interferon (IFN-a) 19 5, 19 7, 19 8–2 01, 238, 242 trials in stage III 19 8–200, 19 9 high-dose 19 9 low-dose 19 9–200 trials in stage II 200 1 g-interferon 19 7, 233, 234, ... base 11 6 free access skin checks 10 9 10 invitation-based screening 11 3 limitations 11 4 primary care level 11 1 public education 10 8–9 purpose 10 6–7 selecti...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 2 pdf
... Germany, 19 94† Never used 310 327 1. 00§ — Exposure starts ≥ 19 80 < ;10 h 36 45 0.75 0.46 1. 25 ≥ 10 h 19 18 0.99 0.49–2.00 Exposure starts < 19 80 < ;10 h 16 15 1. 00 0.47–2 .13 ≥ 10 h 18 7 2 .12 0.84–2 .12 Test ... 523/505 1. 8 (1. 2–2.7) ≠ Elwoood & Canada 19 79– 81 369/369 1. 10 (0.75 1. 62) - Gallagher [45] Holman et al. [46] Australia 19 80– 81 507/5...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 4 pps
... and prognosis of melanoma. Acta Oncol 19 99; 38: 535–47. 3 Flotte TJ. Malignant melanoma in situ. Hum Pathol 19 90; 21: 11 99–2 01. 4 Kirkham N. Optimal handling and criteria for melanoma diagnosis. Histopathology ... melanoma. Hum Pathol 19 84; 15 : 11 47–65. 13 Alper JC, Bogaars H, Sober AJ, Schoenfeld E. The surgical management of in situ melanoma. J Dermatol Surg Oncol 19...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 6 pot
... Oncol 19 99; 17 : 15 08 15 . 37 Calabro A, Singletary SE, Balch CM. Patterns of relapse in 10 01 consecutive patients with melanoma nodal metastases. Arch Surg 19 89; 12 4: 10 51 5. References 14 8 CHAPTER ... Follow-up of patients with a thin melanoma. Br J Surg 19 99; 86: 619 – 21. 25 Kanzler MH. Initial evaluation of melanoma: don’t stop getting that chest X- ray Yet [letter...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 8 pot
... [38] gp100 209 2M IFA 11 3 mixed IFA, IL-2 31 13 1 CR, 12 PR Maeurer et al. [39] MART -1 , gp100, MF59 or Tyrosinase 368 Local IL -1 2 Jaeger et al. [40, 41] MART -1 , gp100, GM-CSF (3 pt) 10 3 1 CR, Tyrosinase ... A24, B37, B44, DR 11, DR13 MAGE-4A 55 11 22 MAGE-6 [63] 89 ? ? MAGE -1 2 89 ? ? MAGE-C1 [36] 37 53 BAGE 22 Cw16 01 GAGE [63] 24 Cw6 LAGE [28] 50 SSX-2 [30] 43 NY-ESO -1 [...
Ngày tải lên: 09/08/2014, 15:20
MELANOMA CRITICAL DEBATES - PART 9 pps
... antigens. The cytokines involved in the T-cell response, such as IFN-g and IL -1 2 , help drive the T-cell response towards cell- mediated immunity, whereas IL-4 and IL -1 0 drive the response towards humoral ... in melanoma. Melanoma Res 19 97; 7: 417 19 . 11 Ghussen F, Kruger I, Groth W, Stutzer H. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity m...
Ngày tải lên: 09/08/2014, 15:20